Research reports

摘要

Lemon myrtle toxicity It is predicted that over the next few years therapeutic products containing Backhousia citriodora (lemon myrtle) will become widespread, since the essential oil has shown significant antimicrobial activity. In human cell lines the no observed adverse effect level (NOAEL) has already been determined as 0.5 mg/l, but the extent of percutaneous absorption was unknown. An Australia duo, (Hayes and Markovic, 2003) examined the in vitro percutaneous absorption of lemon myrtle essential oil in fresh, full thickness human abdominal skin and evaluated any histopathological changes.